Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B

Chul Yoo Byung, Hyun Kim Ju, Young Hwa Chung, Sik Lee Kwan, Woon Paik Seung, Hyung Ryu Soo, Hoon Han Byung, Joon Yeol Han, Soo Byun Kwan, Mong Cho, Heon Ju Lee, Tae Hun Kim, Se Hyun Cho, Joong Won Park, Soon Ho Um, Gyu Hwang Seong, Soo Kim Young, Youn Jae Lee, Yoon Chon Chae, Byung Ik KimYoung Suk Lee, Jin Mo Yang, Cheoul Kim Haak, Seok Hwang Jae, Sung Kyu Choi, Young Oh Kweon, Sook Hyang Jeong, Myung Seok Lee, Jong Young Choi, Dae Ghon Kim, Soo Kim Yun, Young Lee Heon, Kwon Yoo, Hee Won Yoo, Hyo Suk Lee

Research output: Contribution to journalArticlepeer-review

101 Citations (Scopus)

Fingerprint Dive into the research topics of 'Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B'. Together they form a unique fingerprint.

Medicine & Life Sciences